Asian Journal of Social Pharmacy ›› 2019, Vol. 14 ›› Issue (3): 119-125.

Previous Articles     Next Articles

Empirical Study of the Relations between Executive Compensation Gap and R&D Investment in Pharmaceutical Manufacturing Enterprises

Hu Liuyan, Liu Nanping, Xing Hua*   

  1. 1.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China; 2. Shenyang Open University, Shenyang 110016, China
  • Online:2019-09-20 Published:2019-10-12
  • Contact: Xing Hua, doctor, master tutor, associate professor. Major research area: accounting and financial management of pharmaceutical enterprises. Tel: 13504908295, E-mail: gsglxyxh@126. com E-mail:gsglxyxh@126. com

Abstract: Objective To study the correlation between executive compensation gap and R&D investment of pharmaceutical manufacturing enterprises in China by taking 53 pharmaceutical manufacturing companies in Shanghai and Shenzhen stock exchanges from 2015 to 2017 as research samples. Methods Multiple linear regression methods was used to study the relationship and influence between executive compensation gap and R&D investment in pharmaceutical manufacturing industry based on championship theory and principal-agent theory. Results and Conclusion There is a significant positive correlation between executive compensation gap in pharmaceutical manufacturing industry and enterprise R&D investment. Listed pharmaceutical manufacturing enterprises should design reasonable salary gap between senior executives and carry out reasonable research and development activities to promote the sustainable development of pharmaceutical manufacturing enterprises. This study provides theoretical basis for optimizing executive compensation gap and increasing R&D investment in pharmaceutical manufacturing industry.

Key words: executive compensation gap, R&D input, pharmaceutical manufacturing company

Trendmd